BenevolentAI's platform-derived hypothesis for COVID-19 treatment validated in US NIAID randomised control trial - PR Newswire UK

BenevolentAI's platform-derived hypothesis for COVID-19 treatment validated in US NIAID randomised control trial  PR Newswire UK